Ünal Ataş

14PUBLICATIONS

135CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Gene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 25, 2026

Eltrombopag for Chemotherapy-Induced Thrombocytopenia: A Multicenter Retrospective Real-World Study.

|May 27, 2026

JC Virus Reactivation Should Be Considered in Late Neurotoxicity Associated with Bispecific Antibody Therapy: A Comment. Comment on Bangolo et al. Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. <i>Cancers</i> 2025, <i>17</i>, 282.

|Jan 28, 2026

Progressive multifocal leukoencephalopathy associated with elranatamab therapy in relapsed/refractory multiple myeloma.

Tansuhan Çetiner, Merve Çağla Bilek, Selin Arslan Kirezli

|Jan 28, 2026

The Role of Therapeutic Plasma Exchange in the Management of Myeloma-Related Cast Nephropathy: A 10-Year Real-World Cohort Study.

Hasan Salur, Unal Atas, Nurcan Alhan

|Oct 29, 2025

Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry.

Volkan Karakus, Ibrahim Ethem Pinar, Utku Iltar

|Oct 29, 2025

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

Unal Atas, Utku Iltar, Orhan Kemal Yucel

Pageof 3

Frequent Collaborators

Utku Iltar

Ömür Gökmen Sevindik

Volkan Karakus

Fahir Özkalemkaş

Orhan Kemal Yücel

Ozan Salim

Hakkı Onur Kırkızlar

Levent Undar

Muzaffer Keklik

Senem Maral

Frequent Collaborators

Utku Iltar

Ömür Gökmen Sevindik

Volkan Karakus

Fahir Özkalemkaş